CD274 and non-small cell lung carcinoma: We then explored the potential of the photoactive complex between eosin and atezolizumab for the photo-immunotherapy of PD-L1-expressing NSCLC cell lines, and evaluated the relation between the photodynamic treatment outcome and the level of PD-L1 expression.